First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay--Lp(a) SRM 2B
about
Relook at lipoprotein (A): independent risk factor of coronary artery disease in north Indian population.Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study.Racial and Ethnic Variation in Lipoprotein (a) Levels among Asian Indian and Chinese Patients.Lipoprotein(a) is strongly associated with coronary artery calcification in type-2 diabetic women.Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population Study.Lipoprotein (a) measurements for clinical application.Lipoprotein(a) for risk assessment in patients with established coronary artery disease.Lipoprotein(a): A missing culprit in the management of athero-thrombosis?apoB-independent enzyme immunoassay for lipoprotein(a) by capture on immobilized lectin (jacalin).Lipoprotein(a) in clinical practice: New perspectives from basic and translational science.Cardiovascular disease among patients with type 2 diabetes: Role of Homocysteine as an inflammatory marker.Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study.Cardiovascular disease and risk factors: the role of growth hormone.Lipoprotein(a) Levels in Patients With Abdominal Aortic Aneurysm
P2860
Q34002189-C48B50EB-6336-4EEE-B95B-9A3B865ECC20Q34955900-06A915DB-BEEE-49F9-A4B8-B952DB2F1EFBQ35024656-8938593E-4A77-4ECE-8E3D-75F60ACE0202Q35093777-60C453EB-28EE-46F3-83DE-9BF7836490DFQ35737842-21A0E385-21EC-4751-9674-6D3A26C3A3ABQ36731797-22F004C2-2712-4CE5-8300-73106AF04F04Q36731801-ED3406DC-BAD1-44E9-8B10-32D96917ABDEQ37622149-CA53CF53-190F-40B8-9958-33B184FF7FE9Q39368804-16F72B19-ABE9-47FF-B478-9E93B0FD046CQ43969083-431FF751-180F-4C57-90A5-AD4C07B56591Q47274864-3B05D340-3E91-4783-8BAA-23D2C8511C7CQ47672340-22908598-5F4F-4E91-92FA-BC4BE27EFA20Q47677489-880E3ED4-1D30-4DB1-8515-8098277CB3B6Q53877240-683BFD6D-CBE5-4872-A8DD-6AB2E354D890Q58886358-F6A40FA5-9CA4-4A98-B290-009D49A10DC0
P2860
First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay--Lp(a) SRM 2B
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
First WHO/IFCC International R ...... for Immunoassay--Lp(a) SRM 2B
@ast
First WHO/IFCC International R ...... for Immunoassay--Lp(a) SRM 2B
@en
First WHO/IFCC International R ...... for Immunoassay--Lp(a) SRM 2B
@nl
type
label
First WHO/IFCC International R ...... for Immunoassay--Lp(a) SRM 2B
@ast
First WHO/IFCC International R ...... for Immunoassay--Lp(a) SRM 2B
@en
First WHO/IFCC International R ...... for Immunoassay--Lp(a) SRM 2B
@nl
prefLabel
First WHO/IFCC International R ...... for Immunoassay--Lp(a) SRM 2B
@ast
First WHO/IFCC International R ...... for Immunoassay--Lp(a) SRM 2B
@en
First WHO/IFCC International R ...... for Immunoassay--Lp(a) SRM 2B
@nl
P2093
P2860
P921
P356
P1476
First WHO/IFCC International R ...... for Immunoassay--Lp(a) SRM 2B
@en
P2093
Armin Steinmetz
Francesco Dati
Jillian R Tate
Santica M Marcovina
P2860
P356
10.1515/CCLM.2004.114
P407
P577
2004-01-01T00:00:00Z